资讯

Study Links Methylmalonic Acid to Weakening of Immune Cells in Lung Cancer Oct. 31, 2024 — A new study has found a surprising link between high levels of methylmalonic acid and the weakening of ...
BNT327 combined with chemotherapy showed an overall response rate of 85.4% when used as a first-line treatment for extensive-stage small cell lung cancer. Early trial results show combining the ...
Lung cancer liver metastases are tumors that form in the liver from cancer cells that have broken away from the primary cancer and spread through the blood or lymphatic system. The liver is a common ...
Median survival is the amount of time at which 50% of people with a condition 50% are still alive and 50% have died. There are two basic types of lung cancer: small cell (SCLC), the most aggressive ...
But lung cancer is most likely to return within 5 years after you were diagnosed. After treatment, some tiny cancer cells may stay in your body. Over time, these cells may divide and grow into a ...
Lung cancer remains one of the deadliest cancers globally. Non-small cell lung cancer (NSCLC), which accounts for 85% of all lung cancer cases, is particularly challenging to treat due to ...
Researchers in the UK have developed a lung cancer cell line that they believe could be an important new tool for the discovery of new therapies for the disease. The team from Cancer Research UK's ...
31 study showed that giving Imfinzi (durvalumab) as adjuvant therapy for stage IB-IIIA non-small cell lung cancer (NSCLC) was no better than placebo at extending disease-free survival (DFS).
Asbestos lung cancer settlements can award hundreds of thousands of dollars to patients and their loved ones, which can help pay for much-needed medical care. At Sokolove Law, our dedicated team has ...
Among eligible populations, screening for breast and colorectal cancers was nearly four times more common than for lung cancer. Among those who never had lung cancer screening, roughly 60% had ...